Skip to main content
for

Latest Releases

Find our latest releases below. After searching, you can view the most recent releases by clearing the search.

Browse experts on:

View Latest Releases

Search Results

AI gets a cerebellum

July 10, 2026
New device is first to mimic the cerebellum, the brain’s reflex center.
Morticia Addams (dressed in somber black) in conversation with Alice (dressed in bright yellow and pearls) who is the mother of the Wednesday Addams fiance.

Wirtz Centers unveils bold 2026-27 season across Evanston and Chicago

July 9, 2026
From a Tony Award-winning musical to boundary-pushing performances exploring artificial intelligence, justice and identity, Northwestern University’s Virginia Wadsworth Wirtz Centers announce a dynamic 2026-27 season spanning Evanston and Chicago. Across both campuses, the season highlights a bold, collaborative and creative ecosystem where emerging artists take risks, and new work comes to life.

From hantavirus to Ebola, expert urges public health messaging

July 7, 2026
A range of outbreaks, from COVID-19 to hantavirus to Ebola, have highlighted the ongoing need for clear, consistent and non-alarmist public health communication, explains Northwestern Medicine infectious diseases expert Dr. Jennie H. Kwon in a new perspective piece in JAMA Internal Medicine.
* Media Advisory
A woman's hands uncap an Ozempic auto-injector

‘An exceptional opportunity’: Medicare begins covering GLP-1s for seniors

June 30, 2026
Starting July 1, the Centers for Medicare and Medicaid Services (CMS) will allow millions of eligible seniors to access GLP-1 medications for a flat $50 monthly copayment under its temporary pilot program, Medicare GLP-1 Bridge. Northwestern University experts are available to speak to media covering this new initiative.
* Media Advisory
A man in a white coat works at a lab bench

Blood test spots hidden pancreatic cancer after treatment

June 30, 2026
Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer missed by standard testing, potentially helping physicians identify patients whose disease is more likely to return even when scans appear reassuring.